Trials / Recruiting
RecruitingNCT06041594
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 107 (estimated)
- Sponsor
- Innova Vascular, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retriever™ System and the Malibu Aspiration Catheter™ System. These devices are manufactured by Innova Vascular, Inc.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Laguna Thrombectomy System | Removal of clot using the Laguna Thrombectomy System to treat Pulmonary Embolism |
Timeline
- Start date
- 2024-08-19
- Primary completion
- 2026-03-01
- Completion
- 2026-04-01
- First posted
- 2023-09-18
- Last updated
- 2025-10-02
Locations
14 sites across 2 countries: United States, Turkey (Türkiye)
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06041594. Inclusion in this directory is not an endorsement.